Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 16, 2020
New research by Refugees International and the Center for Global Development (CGD) finds that Venezuelans in Peru face major barriers that prevent them from integrating into the Peruvian economy. As a result, many are pushed into informal, low-paying jobs that do not match their qualifications. Some...
Blog Post
December 14, 2020
Tobacco taxes are a highly effective instrument to reduce the consumption of tobacco, discourage new young smokers, raise government revenue, and help reduce the social and economic costs of tobacco products consumption, estimated at 8 million premature deaths per year and costing 1.8 percent of glo...
Blog Post
December 03, 2020
The COVID-19 recession has exacerbated the need for economic inclusion to prevent the most vulnerable from falling into poverty and delaying economic recovery. For the private sector, helping refugees participate in the economy is not only the correct ethical choice, but one which will improve its b...
Blog Post
November 25, 2020
As COVID-19 vaccines begin to emerge, policymakers around the world are feeling buoyant. Although governments will be the initial recipients of vaccines, their decisions on how to distribute these among their populations will be fundamental for the ultimate recipients: individuals.
Blog Post
November 18, 2020
Since the beginning of the outbreak, the scientific community has worked around the clock to produce evidence to support decision-makers in all aspects of COVID management. However, health economics research has been largely missing from this growing literature. The C19economics.org platform has bee...
Blog Post
November 09, 2020
This morning, America (and much of the world) woke up to a snippet of terrific news: Pfizer and BioNTech announced their SARS-CoV2 vaccine candidate showed 90 percent efficacy. But for policymakers in low- and middle-income countries, today’s news offers limited cause for celebration—and the Pfizer/...